Velano Vascular Revenue and Competitors
Estimated Revenue & Valuation
- Velano Vascular's estimated annual revenue is currently $2.6M per year.
- Velano Vascular received $17.0M in venture funding in March 2017.
- Velano Vascular's estimated revenue per employee is $125,500
- Velano Vascular's total funding is $71.2M.
- Velano Vascular has 21 Employees.
- Velano Vascular grew their employee count by -28% last year.
Velano Vascular Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Velano Vascular?
Velano Vascular is transforming the inpatient experience with the PIVO, a breakthrough needle-free blood collection device. PIVO aims to reduce painful needle sticks for inpatients, to improve practitioner safety, and to provide hospitals with a smarter financial solution for vascular access. Velano is backed by leading U.S. health systems including Sutter Health, Griffin Hospital and The Children's Hospital of Philadelphia, as well as First Round Capital, Kapor Capital, White Owl Capital, Safeguard Scientifics and dozens of heath industry veterans. Velano collaborates with innovators in patient-centered care, including Planetree, Intermountain Healthcare, Brigham & Women's Hospital and more. Our mission is to establish a new, more humane standard of care. We're looking for bright, tenacious candidates to join our incredible team of business and healthcare professionals. Check out our careers page here: http://velanovascular.com/careers/keywords:Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals
Number of Employees
Employee Growth %
Velano Vascular News
The major players covered in the needle free blood drawing devices market report are Velano Vascular, Inc., Siemens, Romsons, Tasso, Inc.,...
Velano Vascular, maker of a needle-free blood draw system, has closed a second tranche of new financing with $25 million to put toward its commercialization and launch of additional access products and medical devices for the inpatient setting. Sponsored by Agilent Technologies How would you l ...
“We refer to it as the one-stick hospitalization,” Eric Stone, Velano Vascular’s CEO, said in a phone interview. “Our aim, and I’ve been very open about this, is to make PIVO the standard of care around the world,” he said. More than a billion blood draws take place in inpatient settings per ye ...
Velano Vascular, a San Francisco, Calif. – based vascular access technology company, closed the second tranche of a $25m growth financing. This new investment builds on an initial tranche closed in the first half of 2019 and brings total funding to more than $50 million from a mix of company in ...
SAN FRANCISCO, May 08, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular today announced that it has ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Velano Vascular Funding